Dr. Johan Christenson has been a Partner at HealthCap since 2001. He has been in the life science sector covering science, medicine, drug development and venture investments since 1981. Prior to joining HealthCap, Dr. Christenson was with SEB Företagsinvest (the venture capital arm of SEB) to supervise the health care portfolio. He was Global Product Director and member of the global therapy area management team of Pain and Inflammation at AstraZeneca. He has an MD degree and a PhD in basic neuroscience from Karolinska Institute. He held a position as Assistant Dean at the Karolinska Institute Graduate School for two years.

Ross Hammerman has 19+ years of investment banking experience and joined Deutsche Bank in October 2016. Prior to joining Deutsche Bank, he worked at UBS as Global Head of Life Sciences. Ross has previously worked at Citigroup in Healthcare Investment Banking and Lehman Brothers. He is medically trained in Ob/Gynat the Albert Einstein College of Medicine.

From 1997 to 2011, Leif Johansson was Chief Executive Officer of Volvo. Prior to that, he served at Electrolux, latterly as Chief Executive Officer from 1994 to 1997. He was a Non-Executive Director of BMS from 1998 to September 2011, serving on the Board’s Audit Committee, and Compensation and Management Development Committee. Leif was Chairman of global telecommunications company, LM Ericsson, from 2011 until March 2018. He holds an MSc in engineering from Chalmers University of Technology, Gothenburg. Leif holds board positions at Autoliv, Inc and Ecolean. He has been a member of the Royal Swedish Academy of Engineering Sciences since 1994 (Chairman 2012 to 2017). Leif is also a member of the European Round Table of Industrialists (Chairman 2009 to 2014) and a Member of the Council of Advisors, Boao Forum for Asia.

Dr Kristina Lagerstedt is a health-tech entrepreneur, cancer scientists and expert in DNA-science and a member of Digital Leaders Europe. Kristina is a founder and the CEO of 1928 Diagnostics (Technology Pioneer Champion by World Economic Forum in 2018) providing a software service that decodes DNA from bacteria to guide hospitals to identify and stop deadly outbreaks of antibiotic resistant bacteria. Dr. Lagerstedt was previously a clinical cancer scientist at Sahlgrenska University hospital, Gothenburg, Sweden focused on identifying and commercializing molecular biomarkers and detect new treatment targets to guide and improve cancer treatment.

Jan joined Deutsche Bank in 1988 and has held several positions within M&A, Structured Finance and Corporate Finance. He holds a BA from Pomona College, an MBA from Wharton, an MA from University of Pennsylvania, and a Graduate Diploma in Business Studies from the London School of Economics.

H.E. Torbjörn Sohlström is the Swedish Ambassador to the UK. The Ambassador initially worked in journalism before joining the Swedish Foreign Service. He has worked for the EU at the EU Council Secretariat in Brussels and has had senior postings in Skopje and Pristina, including working as Personal Representative of Javier Solana. He then returned from the EU to the Swedish Foreign Service as Deputy Head of the Mission in Russia, and has held senior positions in Sweden as Deputy Director General and Head of the Minister’s Office, followed by Director General for Political Affairs.